Eyebright Medical Technology Gets Marketing Approval for Intraocular Lens

marketscreener
2025.09.29 08:47
portai
I'm PortAI, I can summarize articles.

(MT Newswires) -- Eyebright Medical Technology (Beijing) (SHA:688050) obtained market registration approval from China's medical products administrator for its extended depth of focus intraocular lens. The product is intended for vision correction after adult cataract surgery, according to a filing with the Shanghai bourse. Shares of the medical device manufacturer closed 2% higher Monday.

Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.